|
| | Publication Year | Title | Author(s) |
| 1 | Mar-2023 | In colon cancer cells fascin1 regulates adherens junction remodeling. | Esmaeilniakooshkghazi, Amin; Pham, Eric; George, Sudeep P; Ahrorov, Afzal; Villagomez, Fabian R; Byington, Michael; Mukhopadhyay, Srijita; Patnaik, Srinivas; Conrad, Jacinta C; Naik, Monali; Ravi, Saathvika; Tebbutt, Niall C ; Mooi, Jennifer K ; Reehorst, Camilla M; Mariadason, John M ; Khurana, Seema |
| 2 | 3-Jan-2023 | Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death. | Jenkins, Laura J; Luk, Ian Y; Fairlie, Walter Douglas ; Lee, Erinna F; Palmieri, Michelle; Schoffer, Kael L; Tan, Tao; Ng, Irvin; Vukelic, Natalia; Tran, Sharon; Tse, Janson W T; Nightingale, Rebecca; Alam, Zakia; Chionh, Fiona; Iatropoulos, George F ; Ernst, Matthias ; Afshar-Sterle, Shoukat ; Desai, Jayesh; Gibbs, Peter; Sieber, Oliver M; Dhillon, Amardeep S ; Tebbutt, Niall C ; Mariadason, John M |
| 3 | 23-May-2022 | Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. | Luk, Ian Y; Jenkins, Laura J; Schoffer, Kael L; Ng, Irvin; Tse, Janson W T; Mouradov, Dmitri; Kaczmarczyk, Stanislaw; Nightingale, Rebecca; Burrows, Allan D; Anderson, Robin L ; Arango, Diego; Dopeso, Higinio; Croft, Larry; Richardson, Mark F; Sieber, Oliver M; Liao, Yang; Mooi, Jennifer K ; Vukelic, Natalia; Reehorst, Camilla M; Afshar-Sterle, Shoukat ; Whitehall, Vicki L J; Fennell, Lochlan; Abud, Helen E; Tebbutt, Niall C ; Phillips, Wayne A; Williams, David S ; Shi, Wei; Mielke, Lisa A; Ernst, Matthias ; Dhillon, Amardeep S; Clemons, Nicholas J; Mariadason, John M |
| 4 | 24-Jan-2022 | VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. | Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 5 | 15-Apr-2021 | Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy J; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 6 | 22-Feb-2021 | Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK. | Lau, David K ; Luk, Ian Y; Jenkins, Laura J; Martin, Andrew; Williams, David S ; Schoffer, Kael L; Chionh, Fiona; Buchert, Michael; Sjoquist, Katrin; Boussioutas, Alex; Hayes, Sarah A; Ernst, Matthias ; Weickhardt, Andrew J ; Pavlakis, Nick; Tebbutt, Niall C ; Mariadason, John M |
| 7 | 29-Jan-2021 | Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 8 | Mar-2020 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. | Williams, David S ; Mouradov, Dmitri; Browne, Clare; Palmieri, Michelle; Elliott, Meg J; Nightingale, Rebecca; Fang, Catherine G; Li, Rita; Mariadason, John M ; Faragher, Ian; Jones, Ian T; Churilov, Leonid ; Tebbutt, Niall C ; Gibbs, Peter; Sieber, Oliver M |
Loading...
2
0
20
0
false